The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 526.00
Bid: 526.00
Ask: 527.00
Change: -3.00 (-0.57%)
Spread: 1.00 (0.19%)
Open: 530.00
High: 530.00
Low: 524.00
Prev. Close: 529.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AUM Update

11 Oct 2018 07:00

RNS Number : 6489D
Polar Capital Holdings PLC
11 October 2018
 

11 October 2018 Polar Capital Holdings plc

AUM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist asset management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM").

 

 

Group AUM (unaudited)

 

Polar Capital reports that as at 30 September 2018 its AUM were £14.7bn compared to £12.0bn at the end of March 2018.

 

AUM movement in six months to 30 September 2018

Long only

funds

Alternative funds

Total

AUM at

1 April 2018

£10,812m

£1,168m

£11,980m

Net subscriptions

/ (redemptions)

£739m

£193m

£932m

Market movement

and performance

£1,668m

£133m

£1,801m

Total AUM at

30 September 2018

£13,219m

£1,494m

£14,713m

 

 

Net performance fees (unaudited)

 

The table below sets out the position relating to net performance fee profits due to the Group (after the deduction of staff interests) as a product of accrued performance fees in funds managed by the Group three months before the strike point of such performance fee receipts. The majority of the Group's performance fees crystallise in the second half of the financial year.

 

Performance fees

net of staff allocations

Six months to

30 Sept 17

Year to

31 Mar 18

(year-end)

Six months to

30 Sept 18

Received

£0.0m

£15.3m

£5.5m

Accrued but not yet earned in funds with year ends on or before the financial year end

£9.6m

n/a

£27.0m*

Total net performance fee profits

£9.6m

£15.3m

£32.5m*

 

*the figures benefit from £4.6m of net performance fee distributions that will be deferred into future accounting periods that IFRS do not allow to be deducted from this year's receipts.

 

 

Comment

 

The Group has had another satisfactory quarter in terms of both performance and flows.

 

As is usual at the time of releasing this update, three months before the crystallisation of performance fees, we disclose the profits that could be due to Polar as a function of the amount of accrued performance fees in our funds as at the end of September. There is no certainty that the fees will be sustained over the next quarter, as performance fee receipts are extremely volatile, but nevertheless the quantum of potential net performance fee receipts is a marked improvement on the position of 2017, which itself was a record year in terms of such performance fee profitability.

 

It is also reassuring to report another quarter of positive net inflows with close to £240m received in the quarter following our first quarter of over £690m of net inflows. The flows this quarter were seen across a number of strategies including: our Technology, Healthcare, Insurance, Convertibles and UK Value strategies. In addition, we have successfully launched our EM Stars, China Stars and China Mercury funds.

 

 

For further information please contact:

 

Polar Capital

Gavin Rochussen (Chief Executive)

John Mansell (COO)

+44 (0)20 7227 2700

 

Canaccord Genuity - Nomad and Joint Broker

Simon Bridges (QE)

David Tyrrell

 

+44 (0)20 7523 8000

 

 

Peel Hunt - Joint Broker

Guy Wiehahn

 

+44 (0)20 7418 8893

 

Camarco

Ed Gascoigne-Pees

 

 

+44 (0)20 3757 4984

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDEASEEFADPFFF
Date   Source Headline
8th Nov 20217:00 amRNSInvestor Presentation covering Interim Results
19th Oct 20219:04 amRNSHolding(s) in Company
18th Oct 20217:00 amRNSNotice of Results
15th Oct 20216:04 pmRNSHolding(s) in Company
14th Oct 20214:00 pmRNSDirector/PDMR Shareholding
14th Oct 20217:00 amRNSAuM Update
4th Oct 202112:08 pmRNSForm 8.3 - Stock Spirits Group PLC
1st Oct 20211:02 pmRNSForm 8.3 - Stock Spirits Group PLC
1st Oct 202112:58 pmRNSDirector/PDMR Shareholding
30th Sep 20213:25 pmRNSForm 8.3 - Stock Spirits Group PLC
29th Sep 20212:24 pmRNSForm 8.3 - Stock Spirits Group PLC
28th Sep 20213:37 pmRNSForm 8.3 - Stock Spirits Group PLC
27th Sep 20212:39 pmRNSForm 8.3 - Stock Spirits Group PLC
24th Sep 20212:15 pmRNSForm 8.3 - Stock Spirits Group PLC
23rd Sep 20211:40 pmRNSForm 8.3 - Stock Spirits Group PLC
22nd Sep 20213:20 pmRNSForm 8.3 - Stock Spirits Group PLC
21st Sep 20211:44 pmRNSForm 8.3 - Stock Spirits Group PLC
20th Sep 20213:01 pmRNSForm 8.3 - Stock Spirits Group PLC
17th Sep 202112:50 pmRNSForm 8.3 - Stock Spirits Group PLC
16th Sep 20211:59 pmRNSForm 8.3 - Stock Spirits Group PLC
8th Sep 20215:53 pmRNSResult of AGM and Directorate Change
3rd Sep 20212:36 pmRNSForm 8.3 - Stock Spirits Group PLC
2nd Sep 20211:39 pmRNSForm 8.3 - Stock Spirits Group PLC
25th Aug 20213:25 pmRNSForm 8.3 - Stock Spirits Group PLC
20th Aug 20214:10 pmRNSForm 8.3 - Ultra Electronics Holdings PLC
20th Aug 202110:41 amRNSHolding(s) in Company
13th Aug 20213:57 pmRNSForm 8.3 - Stock Spirits Group PLC
9th Aug 20213:39 pmRNSForm 8.3 - Restore PLC
6th Aug 20214:38 pmRNSForm 8.3 - RESTORE PLC
2nd Aug 20217:00 amRNSDirector/PDMR Shareholding
2nd Aug 20217:00 amRNSBlock listing Interim Review
23rd Jul 20213:44 pmRNSForm 8.3 - RESTORE PLC
20th Jul 20214:15 pmRNSDirector/PDMR Shareholding
19th Jul 20219:54 amRNSDirector/PDMR Shareholding
13th Jul 20211:02 pmRNSDirector/PDMR Shareholding
12th Jul 202112:38 pmRNSDirector/PDMR Shareholding
8th Jul 20212:07 pmRNSAnnual Financial Report
8th Jul 20217:00 amRNSAuM Update
1st Jul 202111:07 amRNSDividend Declaration
1st Jul 202110:26 amRNSDirector Declaration
1st Jul 20217:00 amRNSGroup Audited Results for year ended 31 March 2021
29th Jun 20213:53 pmRNSForm 8.3 - Ultra Electronics Holdings PLC
7th Jun 20217:00 amRNSNotice of Results
1st Jun 20217:00 amRNSTotal Voting Rights
26th May 20215:35 pmRNSDirector/PDMR Shareholding
21st May 20212:21 pmRNSDirector/PDMR Shareholding
20th May 202111:36 amRNSIssue of Equity
20th May 202110:38 amRNSHolding(s) in Company
19th May 20217:00 amRNSForm 8.3 - Immunodiagnostic Systems Holdings PLC
17th May 202112:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.